1.800.THE FIRM | 1.800.843.3476
The Cochran Firm Legal Blog
With Office Locations Nationwide
Tuesday, May 11, 2010
Glaxo Pays $60 Million to Settle Avandia Cases
GlaxoSmithKline has agreed to pay $60 million to settle about 700 lawsuits filed over side effects of its Avandia diabetes drug, according to a news report. This settlement is said to be the first for personal injury claims against Avandia.
However, the company still faces thousands of lawsuits from other users alleging inadequate warning about the risk of heart attacks, heart failure, and other injuries from the drug.
Some experts estimate that use of Avandia caused between 60,000 and 200,000 heart attacks and deaths in this country from 1999 to 2006. In recent months, critics have launched a new push for its recall. Earlier this year, a Senate report criticized Glaxo for intimidating doctors who spoke out about the side effects of Avandia, and for failing to warn users about the risks it presented.
The Food and Drug Administration is conducting a safety review of Avandia, and expects to complete it in July.
These tragedies illustrate the risks that defective pharmaceutical products pose to the public. At a House subcommittee hearing recently, some lawmakers questioned how the drug ever won approval in the first place. Second thoughts, however, do nothing to help consumers who have suffered injury from defective drugs.
At The Cochran Firm, we understand the anguish of patients who discover that a drug meant to improve their life has only caused them more harm. We believe that every individual to whom such a thing happens deserves vigorous representation. If you believe that you or a family member has suffered injury from a defective drug, please contact us for a confidential consultation at any of our nationwide offices.
However, the company still faces thousands of lawsuits from other users alleging inadequate warning about the risk of heart attacks, heart failure, and other injuries from the drug.
Some experts estimate that use of Avandia caused between 60,000 and 200,000 heart attacks and deaths in this country from 1999 to 2006. In recent months, critics have launched a new push for its recall. Earlier this year, a Senate report criticized Glaxo for intimidating doctors who spoke out about the side effects of Avandia, and for failing to warn users about the risks it presented.
The Food and Drug Administration is conducting a safety review of Avandia, and expects to complete it in July.
These tragedies illustrate the risks that defective pharmaceutical products pose to the public. At a House subcommittee hearing recently, some lawmakers questioned how the drug ever won approval in the first place. Second thoughts, however, do nothing to help consumers who have suffered injury from defective drugs.
At The Cochran Firm, we understand the anguish of patients who discover that a drug meant to improve their life has only caused them more harm. We believe that every individual to whom such a thing happens deserves vigorous representation. If you believe that you or a family member has suffered injury from a defective drug, please contact us for a confidential consultation at any of our nationwide offices.
Labels: main
posted by Benjamin A. Irwin at 10:11 AM
<< Home